Molecular modeling and solubility of olopatadine hydrochloride polymorphs
暂无分享,去创建一个
P. Perjési | H. Napolitano | L. Sallum | A. Camargo | Antônio S. N. Aguiar | Marianna C. Silva | J. L. Martins | Juliane R. Santos
[1] P. Perjési,et al. Chlorine counterion effect into the supramolecular arrangement of phenylephrine solid state , 2022, Computational and Theoretical Chemistry.
[2] N. Dege,et al. Fabrication and Antimicrobial Activity of Poly(lactic acid) Nanofibers Containing Firstly Synthesized Silver Diclofenac Complex with (2-methylimidazole) for Wound Dressing Applications , 2021, Fibers and Polymers.
[3] U. M. Güven,et al. In vitro-in vivo evaluation of olopatadine incorporated chitosan nanoparticles for the treatment of ocular allergy , 2021 .
[4] Rubén M. Maggio,et al. A comprehensive approach toward concomitant triclabendazole polymorphism in pharmaceutical products , 2021 .
[5] N. Dege,et al. Crystal structure and Hirshfeld surface analysis of 2-methyl-3-nitro-N-[(E)-(5-nitrothiophen-2-yl)methylidene]aniline , 2021, Acta crystallographica. Section E, Crystallographic communications.
[6] M. Guerain. A review on high pressure experiments for study of crystallographic behavior and polymorphism of pharmaceutical materials. , 2020, Journal of pharmaceutical sciences.
[7] M. Neumann,et al. How many ritonavir cases are there still out there? , 2018, Faraday discussions.
[8] Christa Boer,et al. Correlation Coefficients: Appropriate Use and Interpretation , 2018, Anesthesia and analgesia.
[9] L. J. Chen,et al. Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis , 2017, Ocular immunology and inflammation.
[10] A. Nokhodchi,et al. Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges. , 2017, Advanced drug delivery reviews.
[11] A. Witkowska,et al. Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs. , 2016, Journal of pharmaceutical sciences.
[12] J. Bernstein,et al. Facts and fictions about polymorphism. , 2015, Chemical Society reviews.
[13] E. Stefánsson,et al. Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops , 2015, Pharmaceutical development and technology.
[14] J. Bosch,et al. Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer. , 2012, The Journal of organic chemistry.
[15] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[16] Debayan Sarkar,et al. Use of π–π forces to steer the assembly of chromone derivatives into hydrogen bonded supramolecular layers: crystal structures and Hirshfeld surface analyses , 2011 .
[17] V. Torchilin,et al. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel. , 2011, Physical chemistry chemical physics : PCCP.
[18] L Hunt,et al. The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health , 2011, Clinical pharmacology and therapeutics.
[19] Dylan Jayatilaka,et al. Hirshfeld surface analysis , 2009 .
[20] E. Pidcock,et al. Analysis of the compression of molecular crystal structures using Hirshfeld surfaces , 2008 .
[21] D. Truhlar,et al. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .
[22] M. Spackman,et al. Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. , 2007, Chemical communications.
[23] M. Spackman,et al. Comparison of Polymorphic Molecular Crystal Structures through Hirshfeld Surface Analysis , 2007 .
[24] Yan Zhao,et al. Exchange-correlation functional with broad accuracy for metallic and nonmetallic compounds, kinetics, and noncovalent interactions. , 2005, The Journal of chemical physics.
[25] Sarah K Branch,et al. Guidelines from the International Conference on Harmonisation (ICH). , 2005, Journal of pharmaceutical and biomedical analysis.
[26] Peter Politzer,et al. The fundamental nature and role of the electrostatic potential in atoms and molecules , 2002 .
[27] M. Spackman,et al. Fingerprinting intermolecular interactions in molecular crystals , 2002 .
[28] S. Chemburkar,et al. Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development , 2000 .
[29] Raymond E. Davis,et al. Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .
[30] J. V. Lenthe,et al. State of the Art in Counterpoise Theory , 1994 .
[31] Peter Politzer,et al. Use of the electrostatic potential at the molecular surface to interpret and predict nucleophilic processes , 1990 .
[32] Ralph G. Pearson,et al. Absolute hardness: companion parameter to absolute electronegativity , 1983 .
[33] F. L. Hirshfeld. Bonded-atom fragments for describing molecular charge densities , 1977 .
[34] P. Ray,et al. Synergistic effect of various intermolecular interactions on self-assembly and optoelectronic behaviour in co-crystals/salts of tetrabromoterephthalic acid: a report on their structure, theoretical study and Hirshfeld surface analysis , 2020 .
[35] R. Tekade,et al. Polymorphism and its Implications in Pharmaceutical Product Development , 2018 .
[36] Tejender S. Thakur,et al. Crystal Polymorphism in Pharmaceutical Science , 2017 .
[37] G. Iyer,et al. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits. , 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[38] R. Bader,et al. Atoms in molecules , 1990 .
[39] Weitao Yang,et al. Local softness and chemical reactivity in the molecules CO, SCN− and H2CO , 1988 .